Your browser doesn't support javascript.
loading
Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas.
Sertier, Anne-Sophie; Ferrari, Anthony; Pommier, Roxane M; Treilleux, Isabelle; Boyault, Sandrine; Devouassoux-Shisheboran, Mojgan; Kielbassa, Janice; Thomas, Emilie; Tonon, Laurie; Le Texier, Vincent; Charreton, Amandine; Morel, Anne-Pierre; Floquet, Anne; Joly, Florence; Berton-Rigaud, Dominique; Ferron, Gwenaël; Arnould, Laurent; Croce, Sabrina; Bataillon, Guillaume; Saintigny, Pierre; Mery-Lamarche, Eliane; Sagan, Christine; Senaratne, Aruni P; Gut, Ivo G; Calvo, Fabien; Viari, Alain; Ouzounova, Maria; Ray-Coquard, Isabelle; Puisieux, Alain.
Afiliação
  • Sertier AS; Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard, Lyon, France.
  • Ferrari A; Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard, Lyon, France.
  • Pommier RM; Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard, Lyon, France.
  • Treilleux I; Centre Léon Bérard, Lyon, France.
  • Boyault S; Department of Pathology, Centre Léon Bérard, Lyon, France.
  • Devouassoux-Shisheboran M; Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard, Lyon, France.
  • Kielbassa J; Centre Léon Bérard, Lyon, France.
  • Thomas E; Department of Pathology, Hospices Civils de Lyon, Lyon, France.
  • Tonon L; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
  • Le Texier V; Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard, Lyon, France.
  • Charreton A; Centre Léon Bérard, Lyon, France.
  • Morel AP; Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard, Lyon, France.
  • Floquet A; Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard, Lyon, France.
  • Joly F; Synergie Lyon Cancer, Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard, Lyon, France.
  • Berton-Rigaud D; Centre Léon Bérard, Lyon, France.
  • Ferron G; Centre Léon Bérard, Lyon, France.
  • Arnould L; Institut Bergonié Comprehensive Cancer Centre, Bordeaux, France.
  • Croce S; Centre François Baclesse, Caen, France.
  • Bataillon G; Institut de Cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France.
  • Saintigny P; Institut Claudius-Regaud, IUCT Oncopole, Toulouse, France.
  • Mery-Lamarche E; Department of Pathology, Centre Georges François Leclerc, Comprehensive Cancer Centre, Dijon, France.
  • Sagan C; Department of Biopathology, Institut Bergonié Comprehensive Cancer Centre, Bordeaux, France.
  • Senaratne AP; Service de Pathologie, Institut Curie, Paris, France.
  • Gut IG; Centre Léon Bérard, Lyon, France.
  • Calvo F; Department of Translational Medicine, Centre Léon Bérard, Lyon, France.
  • Viari A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Ouzounova M; Institut Claudius-Regaud, IUCT Oncopole, Toulouse, France.
  • Ray-Coquard I; Institut de Cancérologie de l'Ouest René-Gauducheau, Saint-Herblain, France.
  • Puisieux A; Institut Curie, PSL Research University, Paris, France.
Cancer Res Commun ; 3(5): 830-841, 2023 05.
Article em En | MEDLINE | ID: mdl-37377900

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Sarcoma / Carcinossarcoma Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Sarcoma / Carcinossarcoma Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Res Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França